Trial NCT03452527

View at ClinicalTrials.gov 
Org. Study IDs: IT-004

Last trial update was posted on 2021-04-13

MeSH Interventions

Aflibercept Immunoconjugates

MeSH Conditions

Choroidal Neovascularization Macular Degeneration Neovascularization, Pathologic Wet Macular Degeneration

Other Conditions


Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID